ArticleScientific reports2016

A platinum-based hybrid drug design approach to circumvent acquired resistance to molecular targeted tyrosine kinase inhibitors.

Yuming Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.